logo-alt.png
Global Lung Cancer Diagnostic Test Market is estimated to be US$ 4.07 billion by 2030 with a CAGR of 7.50% during the forecast period - By PMI
April 19, 2022 09:52 ET | PMI
Covina, April 19, 2022 (GLOBE NEWSWIRE) -- Lung cancer starts in the lungs and can spread to the lymph nodes or other body organs, including the brain. Cancer that has progressed to other organs can...
logo-alt.png
Global Bioinformatics Platform Market is estimated to be US$ 14.0 Billion by 2029 with a CAGR of 14.7% during the Forecast Period - PMI
June 15, 2020 11:35 ET | PMI
Covina, CA, June 15, 2020 (GLOBE NEWSWIRE) -- The global bioinformatics platform market accounted for US$ 3.6 billion in 2019 and is estimated to be US$ 14.0 billion by 2029 and is anticipated to...
LOGO-01.png
Burning Rock deepens cooperation with Illumina to promote development and standardization of NGS-based cancer therapy selection in China
May 10, 2020 20:00 ET | Burning Rock Biotech Limited
SHANGHAI, China, May 10, 2020 (GLOBE NEWSWIRE) -- Burning Rock and Illumina (NASDAQ: ILMN), a global leader in gene sequencing and array-based technologies, jointly announced today that they are...
Shareholders Foundation
Update: Lawsuit for Investors in NASDAQ: ILMN shares against Illumina, Inc. announced by Shareholders Foundation
June 12, 2018 09:10 ET | Shareholders Foundation, Inc.
SAN DIEGO, June 12, 2018 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Illumina, Inc. (NASDAQ:ILMN).  Investors, who...
real.jpg
Harvard Pilgrim and Illumina sign first-of-its-kind value-based contract
February 20, 2018 10:00 ET | Real Endpoints
SAN DIEGO, WELLESLEY, Mass. and WESTPORT, Conn., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Illumina, Inc. and Harvard Pilgrim Health Care announced on February 1 a major new value-based contract (VBC) – one...
ILMN LOSS ALERT: Rosen Law Firm Reminds Illumina, Inc. Investors of Important Deadline in Class Action – ILMN
January 24, 2017 20:35 ET | The Rosen Law Firm PA
NEW YORK, Jan. 24, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Illumina, Inc. securities (NASDAQ:ILMN) from July 26, 2016 through October 10,...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Illumina, Inc. – ILMN
January 06, 2017 12:21 ET | The Rosen Law Firm PA
NEW YORK, Jan. 06, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Illumina, Inc. securities...
Cloudera Becomes Founding Member of Lockheed Martin Healthcare Technology Alliance
August 03, 2015 07:00 ET | Cloudera Inc.
PALO ALTO, Calif., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Cloudera, the leader in enterprise analytic data management powered by Apache Hadoop™, today announced it has joined a new healthcare...
GenoLogics Life Sciences Software Inc Logo
Illumina CLIA lab subscribes to Clarity LIMS to augment existing informatics infrastructure
February 25, 2013 07:00 ET | GenoLogics Life Sciences Software Inc
Victoria, BC, Canada, Feb. 25, 2013 (GLOBE NEWSWIRE) -- GenoLogics Life Science Software, a leading provider of laboratory information management systems (LIMS) designed for today's omics labs...
Invivoscribe Launches Genection, a New Personalized Molecular Medicine Company Delivering Global Access to the Entire Clinically-Actionable Genetic Test Menu
December 04, 2012 08:36 ET | Invivoscribe
SAN DIEGO, CA--(Marketwire - Dec 4, 2012) - Invivoscribe Technologies, Inc., a privately-held life science company based in San Diego, California, announces the launch of Genection, Inc. ...